Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

Philips

AGFA 1400x150

Petal Health

Petal Health 1400x150

Diagnostics

The latest in breast imaging technology now at St. Joseph’s

July 3, 2018


LONDON, ONT. – The latest wave in breast imaging technology has arrived at St. Joseph’s Health Care London and is making a significant difference in precision and confidence in diagnosing or ruling out breast cancer.

Contrast-enhanced mammography and tomosynthesis (three-dimensional mammography), are both now in use by St. Joseph’s Breast Care Program.

The cutting-edge, new imaging tools are resulting in more accurate diagnoses, reducing the need for follow-up visits, decreasing unnecessary biopsies, enhancing critical information required by breast surgeons, and speeding up the overall diagnostic process, which improves access to breast assessment for all patients.

“We have been practicing the same way for 30 years,” says Dr. Anat Kornecki, Breast Radiology Lead at St. Joseph’s. “Now change has arrived, and it’s here. It shifts the entire paradigm of how we think when it comes to assessing breast abnormalities.”

In July 2017, St. Joseph’s became the first hospital in Canada to install the Senographe Pristina mammography machine from GE Healthcare, a groundbreaking new breast imaging platform designed to increase patient comfort and make the exam easier and faster.

Since being installed, the unit has been used for routine breast screening at St. Joseph’s. Three additional Senographe Pristina units are now in place for breast assessment and diagnosis – when an abnormality has been found. These new units have the added capability of performing contrast-enhanced mammograms and tomosynthesis.

Contrast mammography, developed in the early 2000s and refined and validated over the past decade, combines conventional digital diagnostic mammography with the administration of a contrast agent, explains Dr. Kornecki. The contrast agent – radiographic dye containing iodine – is injected into a vein in the patient’s arm before the mammogram images are taken.

With contrast-enhanced mammography, the area of concern within the breast is highlighted in much more detail and can be an alternative to MRI, says Dr. Kornecki. It can pinpoint cancers that can’t be seen with standard mammography and is particularly effective in assessing dense breasts.

“When the contrast mammogram rules out the presence of cancer, we can trust that there is nothing there. We have confidence in telling the patient that they don’t have cancer,” she said. “If cancer is detected, it tells us how extensive it is.”

Those considered for contrast mammography are patients who have had a screening mammogram that indicated something suspicious, or those with a lump they can feel that is considered concerning.

It’s a quick exam, eliminates having to wait for an MRI, and can be followed by a biopsy on the same day.

PreviousNext

CHT print

CHT print

e-Messenger

  • Niagara Health to deploy top-flight CT scanners
  • BC extends cost-reduction search to regional authorities
  • Osler uses Sectra’s AI service to enhance patient care
  • Waypoint Centre to deploy A4i platform
  • Island Health brings virtual psychiatry to rural communities
More from e-Messenger

Subscribe

Subscribe

Weekly blasts are sent each month, via e-mail, to over 7,000 senior managers and executives in hospitals, clinics and health regions. Learn More

Infoway

Infoway

Zebra

Zebra

Zebra

Zebra

Advertise with us

Advertise with us

Sectra KLAS

Sectra KLAS

Stratford Group

Stratford Group

Pure Storage

Pure Storage

Medirex

Medirex

NIHI

NIHI

CHT print

CHT print

Advertise with us

Advertise with us

Sectra KLAS

Sectra KLAS

Stratford Group

Stratford Group

Pure Storage

Pure Storage

Medirex

Medirex

NIHI

NIHI

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 204
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2025 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us